Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
121 hedge funds and large institutions have $423M invested in Surmodics in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 47 increasing their positions, 37 reducing their positions, and 7 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 37
20% more call options, than puts
Call options by funds: $177K | Put options by funds: $147K
8% more capital invested
Capital invested by funds: $391M → $423M (+$32.3M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less funds holding
Funds holding: 123 → 121 (-2)
3.44% less ownership
Funds ownership: 91.84% → 88.4% (-3.4%)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$2.04M |
| 2 |
Millennium Management
New York
|
+$1.47M |
| 3 |
BlackRock
New York
|
+$1.45M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$1.16M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$888K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.71M |
| 2 |
Renaissance Technologies
New York
|
-$1.98M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$782K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$515K |
| 5 |
MPI
Mairs & Power Inc
St Paul,
Minnesota
|
-$346K |
SRDX Hedge Fund Activity: Q4 2022 in Review
121 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q4 2022, worth a combined $423M — up 8.3% from $391M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of SRDX and 6 opened new positions — a net loss of 1 holder — while 37 trimmed existing stakes and 47 added.
The largest buyer was Trigran Investments, adding an estimated $2.04M. The largest seller was Wellington Management Group, cutting an estimated $5.71M.
- 121 institutional investors held Surmodics (SRDX) as of Q4 2022, down from 123 in Q3 2022.
- Funds reported $423M of Surmodics stock for Q4 2022, up 8.3% quarter-over-quarter.
- 6 funds opened new Surmodics positions in Q4 2022 and 7 closed out, a net change of -1 holder.
- The largest Surmodics buyer in Q4 2022 was Trigran Investments, an estimated $2.04M added.
- The largest Surmodics seller in Q4 2022 was Wellington Management Group, an estimated $5.71M sold.
Based on aggregated 13F filings for Q4 2022.